CoChat

Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial

Dietrich, Detlef E, Bode, Liv, Spannhuth, Carsten W, Lau, Timo, Huber, Thomas J, Brodhun, Bonita, Ludwig, Hanns, Emrich, Hinderk M · 2000 · Bipolar Disorders
Cited by 58

The DOI matches its Crossref record.

Abstract

Objective: Originally introduced into pharmacotherapy as an antiviral compound, amantadine was shown to also have multiple pharmacological effects on the central nervous system. In addition, only a few studies reported on certain antidepressive properties of amantadine. This effect was highlighted by the discovery of its antiviral effect on Borna disease virus (BDV), which is hypothesized to be an etiopathogenetic factor to subtypes of affective disorders. Therefore, the therapeutical use of amantadine in BDV‐infected depressive patients was investigated. Methods: In this open trial, amantadine was added to antidepressive and/or mood‐stabilizing compounds treating BDV‐infected depressed patients (n=25) with bipolar or major depressive disorders. Amantadine was given twice a day (100–300 mg/day) for a mean of 11 weeks. Antidepressive treatment response was measured on the Hamilton rating scale for depression (HAM‐D) and/or with an operationalized diagnostic criteria system (OPCRIT; version 3.31). Virological response was measured by expression of BDV infection parameters in blood samples. Results: The overall response rate of the amantadine augmentation in the BDV‐infected patients with regard to depressive symptoms was 68% after a mean of 2.9 weeks of treatment. Bipolar I patients improved faster and did not show any following hypomania. In addition, the decrease of depression tended to correspond with the decrease in viral activity. Conclusion: Amantadine appears to show a remarkable antidepressive efficacy in BDV‐infected depressive patients. The antidepressive effect in this open trial appeared to be comparable to standard antidepressives, possibly being a result of its antiviral effect against BDV as a potentially relevant etiopathogenetic factor in these disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1034/j.1399-5618.2000.020110.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 58

Metadata

Authors
Dietrich, D. E., Bode, L., Spannhuth, C. W., Lau, T., Huber, T. J., Brodhun, B., Ludwig, H., & Emrich, H. M.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2000-03
Volume
2
Issue
1
Pages
65-70
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2078029525
Cited by
58
References
0
FWCI
1.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. https://app.cochat.ai/papers/10.1034/j.1399-5618.2000.020110.x
The paper
Dietrich, D. E., Bode, L., Spannhuth, C. W., Lau, T., Huber, T. J., Brodhun, B., Ludwig, H., & Emrich, H. M. (2000). Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. Bipolar Disorders. https://doi.org/10.1034/j.1399-5618.2000.020110.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.